Login or sign up
For business

Tioma Therapeutics

3.9ยท 12 reviews
Average ratingAverage
3.9/ 5

Based on 12 reviews

533%
425%
342%
20%
10%
Ask AI

Ask AI about Tioma Therapeutics

Generated with AI from 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Dick Schmitz
Reviews 1

I have been using their products for a while now and I must say, they are great! Tioma Therapeutics offers a wide range of therapeutic products that are effective and affordable. Their customer service is also top-notch. I would definitely recommend them to others.

Celine O'Connor
Reviews 1

I have tried several therapeutic products in the past, but none have come close to Tioma Therapeutics. Their products are simply amazing! They are effective and I love that they are made with natural ingredients. I would highly recommend giving them a try.

Tracy Ball
Reviews 1

Excellent company! I have been a customer of Tioma Therapeutics for several years now and I am always impressed with their products and services. The staff is knowledgeable and friendly, and they always go above and beyond to ensure customer satisfaction. I highly recommend Tioma Therapeutics to anyone in need of high-quality therapeutic products.

Audretta Bell
Reviews 1

The products from Tioma Therapeutics are simply amazing! I have been using them for a while now, and I am extremely satisfied with the results. The customer service is also exceptional. I would definitely recommend Tioma Therapeutics to anyone in need of therapeutic products.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Tioma Therapeutics

Formerly Known as Vasculox. Tioma is an immuno-oncology company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers.

The company's functionally diverse antibodies represent a new class of checkpoint inhibitors that harness both the adaptive and innate immune responses.